Indeed, lipid metabolism deficiency has been investigated in lipocalin-type PGD2 synthase (L-Pgds)-knockout (KO) mice and kidney dysfunction patients, which have a susceptibility to glucose intolerance, accelerated insulin resistance, and aggravated obesity [36, 37]. This evidence concerns the gene PTGDS and Glucose intolerance.